Mackenzie Financial’s Disc Medicine IRON Stock Holding History

Mackenzie Financial’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.82M	Buy	+27,823	New	+$2.1M	﹤0.01%	1063

Other funds holding IRON

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Atlas Venture Life Science Advisors Cambridge, Massachusetts $631M AUM 38.42% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Mackenzie Financial's IRON Position: Q3 2026 in Review

Mackenzie Financial opened a new position in Disc Medicine (IRON) in Q3 2026: 27,823 shares worth $1.82M. The stake represents ﹤0.01% of the portfolio and ranks #1063 among its holdings.

97 funds tracked by Wall St. Rank hold IRON as of Q3 2026.

Mackenzie Financial held 27,823 shares of Disc Medicine worth $1.82M as of Q3 2026.
Disc Medicine was a new Mackenzie Financial position in Q3 2026.
Disc Medicine made up ﹤0.01% of Mackenzie Financial's portfolio in Q3 2026, its #1063 holding.
97 funds tracked by Wall St. Rank held Disc Medicine as of Q3 2026.

Based on Mackenzie Financial's 13F filing for Q3 2026, filed 2 Nov 2026.